These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
459 related items for PubMed ID: 21175542
1. Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy. Hasegawa M, Kondo F, Yamamoto K, Murakami K, Tomita M, Nabeshima K, Nakai S, Kato M, Ohashi A, Arai J, Hiki Y, Ishii J, Emi N, Sugiyama S, Yuzawa Y. Ther Apher Dial; 2010 Oct; 14(5):451-6. PubMed ID: 21175542 [Abstract] [Full Text] [Related]
2. Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis. Hutchison CA, Heyne N, Airia P, Schindler R, Zickler D, Cook M, Cockwell P, Grima D. Nephrol Dial Transplant; 2012 Oct; 27(10):3823-8. PubMed ID: 22273664 [Abstract] [Full Text] [Related]
3. Effectiveness of haemodiafiltration with ultrafiltrate regeneration in the reduction of light chains in multiple myeloma with renal failure. Pendón-Ruiz de Mier MV, Alvarez-Lara MA, Ojeda-López R, Martín-Malo A, Carracedo J, Caballero-Villarraso J, Alonso C, Aljama P. Nefrologia; 2013 Nov 13; 33(6):788-96. PubMed ID: 24241366 [Abstract] [Full Text] [Related]
5. The rationale and evidence base for the direct removal of serum-free light chains in the management of myeloma kidney. Cockwell P, Cook M. Adv Chronic Kidney Dis; 2012 Sep 13; 19(5):324-32. PubMed ID: 22920643 [Abstract] [Full Text] [Related]
9. Management options for cast nephropathy in multiple myeloma. Cockwell P, Hutchison CA. Curr Opin Nephrol Hypertens; 2010 Nov 13; 19(6):550-5. PubMed ID: 20827195 [Abstract] [Full Text] [Related]
10. Bortezomib-dexamethasone combination in a patient with refractory multiple myeloma and impaired renal function. Nozza A, Siracusano L, Armando S. Clin Ther; 2006 Jun 13; 28(6):953-9. PubMed ID: 16860177 [Abstract] [Full Text] [Related]
11. Treatment by long haemodialysis sessions with high cut-off filters in myeloma cast nephropathy: our experience. Borrego-Hinojosa J, Pérez-del Barrio MP, Biechy-Baldan Mdel M, Merino-García E, Sánchez-Perales MC, García-Cortés MJ, Ocaña-Pérez E, Gutiérrez-Rivas P, Liébana-Cañada A. Nefrologia; 2013 Jun 13; 33(4):515-23. PubMed ID: 23897183 [Abstract] [Full Text] [Related]
14. Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy. Rousseau-Gagnon M, Agharazii M, De Serres SA, Desmeules S. PLoS One; 2015 Jun 13; 10(10):e0140463. PubMed ID: 26466100 [Abstract] [Full Text] [Related]
15. A novel option for reducing free light chains in myeloma kidney: supra-hemodiafiltration with endogenous reinfusion (HFR). Pasquali S, Iannuzzella F, Corradini M, Mattei S, Bovino A, Stefani A, Palladino G, Caiazzo M. J Nephrol; 2015 Apr 13; 28(2):251-4. PubMed ID: 25149172 [Abstract] [Full Text] [Related]
16. Serum Free Light Chains Removal by HFR Hemodiafiltration in Patients with Multiple Myeloma and Acute Kidney Injury: a Case Series. Menè P, Giammarioli E, Fofi C, Antolino G, Verde G, Tafuri A, Punzo G, Festuccia F. Kidney Blood Press Res; 2018 Apr 13; 43(4):1263-1272. PubMed ID: 30078004 [Abstract] [Full Text] [Related]